Results 141 to 150 of about 192,096 (187)
Some of the next articles are maybe not open access.
Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie, 1997
Among the approaches which have been followed to convert a natural antisense phosphodiester oligonucleotide into a potential therapeutic agent, conjugation chemistry seems to be one of the most attractive. Indeed, natural phosphodiester oligonucleotide have the ideal properties (sequence specific hybridization, RNaseH activation, low or no toxicity ...
openaire +3 more sources
Among the approaches which have been followed to convert a natural antisense phosphodiester oligonucleotide into a potential therapeutic agent, conjugation chemistry seems to be one of the most attractive. Indeed, natural phosphodiester oligonucleotide have the ideal properties (sequence specific hybridization, RNaseH activation, low or no toxicity ...
openaire +3 more sources
An Antisense Oligonucleotide to Target the RAAS
Nature Reviews Cardiology, 2021Irene Fernández-Ruiz
exaly
Seminars in cancer biology, 1992
Growing evidence indicates that antisense oligodeoxynucleotides can specifically inhibit gene expression thereby providing an essential tool for understanding gene function and the potential to affect abnormal cell proliferation. Because oncogene activation is intimately involved in tumour initiation and progression, down-regulation of oncogene ...
CALABRETTA, Bruno, Skorski T, Zon G.
openaire +2 more sources
Growing evidence indicates that antisense oligodeoxynucleotides can specifically inhibit gene expression thereby providing an essential tool for understanding gene function and the potential to affect abnormal cell proliferation. Because oncogene activation is intimately involved in tumour initiation and progression, down-regulation of oncogene ...
CALABRETTA, Bruno, Skorski T, Zon G.
openaire +2 more sources
Antisense Oligonucleotides as Antiviral Agentsa
Annals of the New York Academy of Sciences, 1992J, Coulson, A D, Malcolm
openaire +3 more sources
Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
New England Journal of Medicine, 2020John Ravits +2 more
exaly
Antisense oligonucleotide therapeutics
Expert Opinion on Investigational Drugs, 1999openaire +2 more sources
An Antisense Oligonucleotide Primer
Antisense and Nucleic Acid Drug Development, 1999openaire +2 more sources
PIKFYVE ANTISENSE OLIGONUCLEOTIDES
2022CHANG WEN-HSUAN, LEE EMILY ELIZABETH
openaire +3 more sources

